Echo Therapeutics is developing its non-invasive, wireless, continuous glucose monitoring (CGM) system. A significant opportunity exists for the Company’s CGM to be used in the outpatient diabetes market and in the fitness, weight loss and personal lifestyle wearable-health space. A longer-term opportunity also exists in the hospital settings. Echo developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, and enhanced delivery of topical pharmaceuticals.
View Top Employees from Echo TherapeuticsWebsite | http://www.echotx.com |
Ticker | ECTE |
Revenue | $57000 |
Employees | 8 (8 on RocketReach) |
Founded | 1989 |
Address | 99 Wood Ave S Ste 302, Iselin, New Jersey 08830, US |
Phone | (732) 549-0128 |
Technologies |
HTML,
Apache,
Apache HTTP Server
+3 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Manufacturing General, Therapeutic Devices, Non-Invasive Sensing Technologies, Manufacturing, Continuous Glucose Monitoring, Medical Devices |
Web Rank | 22 Million |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Echo Therapeutics employee's phone or email?
The Echo Therapeutics annual revenue was $57000 in 2024.
Alan Schoenbart is the Chief Executive Officer and Chief Financial Officer of Echo Therapeutics.
8 people are employed at Echo Therapeutics.
Echo Therapeutics is based in Iselin, New Jersey.
The NAICS codes for Echo Therapeutics are [32, 3254, 325, 32541].
The SIC codes for Echo Therapeutics are [384, 38].